---
granola_id: da19d3ea-ae9c-4906-8070-8e6d65408f38
title: "Grant Blevins and Virtue"
type: note
created: 2025-04-29T20:03:52.573Z
updated: 2025-04-29T20:44:23.799Z
attendees:
  - grant@healthvelocitycapital.com
  - sd@virtuevc.com
---
### Business Overview & Traction

- Current ARR: $2-3M across different product lines
- Gross margins: 80-90% across products
- PMPM fees ranging from $5-7 (one account at $8+)
- Target market: 1,000-2,500 employee groups
- PMPM guarantee margins around 80-90%
- Pipeline expected to add $3-4M over next 6-9 months
- 24 months runway currently

### Key Team & Partnerships

- Bill Wolfe identified as strong operator complementing Hari’s product/thematic focus
- RxBenefits partnership discussions ongoing
- Cigna/ESI showing interest in partnership possibilities
- Sandy Clarke (led Blue Shield of California’s pharmacy reimagined) being connected
- Working with transparent PBMs: MedImpact, Smith Rx, Capital Rx

### Funding Discussion

- Looking at $10-12M raise for 20% equity ($50-60M post)
- Timing: Originally targeting Q3, but potentially open to earlier
- Not actively seeking capital but open to right partners
- Goal is to minimize number of capital partners
- Current investors likely to participate significantly

### Strategic Opportunities & Growth

- Potential to carve out pharmacy from medical insurance
- Opportunity to take full risk on pharmacy benefits
- Targeting larger employer groups (>200 employees)
- Multiple growth paths identified:
	- Conservative path with single $10-12M raise
	- Aggressive path with initial raise followed by larger round in 1-2 years
- Focus on both MGU product and PMPM guarantee SaaS product

### Next Steps

- Grant to follow up with Hari about conversation
- Team to complete reinvestment diligence over next few weeks
- Board meeting scheduled in two weeks for updates
- Continue exploring potential partnerships with major PBMs

Chat with meeting transcript: https://notes.granola.ai/d/da19d3ea-ae9c-4906-8070-8e6d65408f38
